SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice
Authors:
- Mami IshidaMIMami Ishida
- Hajime KomanoHKHajime Komano
- Hiroshi TakahashiHTHiroshi Takahashi
- 1 August 2008
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 441 (1) , 90-93
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Tau-mediated neurodegeneration in Alzheimer's disease and related disordersNature Reviews Neuroscience, 2007
- SUMO on the road to neurodegenerationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-SynucleinJournal of Biological Chemistry, 2006
- SUMOMolecular Cell, 2005
- Systematic Identification and Analysis of Mammalian Small Ubiquitin-like Modifier SubstratesJournal of Biological Chemistry, 2005
- SUMO protein modificationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2004
- Analysis of tauopathies with transgenic miceTrends in Molecular Medicine, 2001
- SUMO-1 Modification of IκBα Inhibits NF-κB ActivationMolecular Cell, 1998
- UBIQUITIN-DEPENDENT PROTEIN DEGRADATIONAnnual Review of Genetics, 1996
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996